![Ian Gourley](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ian Gourley
Chief Tech/Sci/R&D Officer at
IMMUNOVANT, INC.
Profile
Ian Gourley is currently a Member at The Royal College of Physicians and Vice President-Clinical Development at Immunovant, Inc. since 2022.
Former roles include Director-HLA Laboratory at The American Society For Histocompatibility & Immunogenetics, Head-Clinical Research Pathologist at Eli Lilly & Co., and Head-Translational Medical Science at Janssen Pharmaceuticals, Inc. Education includes a graduate degree from Queen's University of Belfast.
Ian Gourley active positions
| Companies | Position | Start |
|---|---|---|
| IMMUNOVANT, INC. | Chief Tech/Sci/R&D Officer | 31/05/2022 |
The Royal College of Physicians
 The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Former positions of Ian Gourley
| Companies | Position | End |
|---|---|---|
| ELI LILLY AND COMPANY | Corporate Officer/Principal | - |
The American Society For Histocompatibility & Immunogenetics
 The American Society For Histocompatibility & Immunogenetics Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization related to histocompatibility and immunogenetics | Corporate Officer/Principal | - |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Corporate Officer/Principal | - |
Training of Ian Gourley
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
86
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Eli Lilly & Co.
 Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Janssen Pharmaceuticals, Inc.
Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets prescription drugs | Health Technology |
Queen's University of Belfast
 Queen's University of Belfast Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The Royal College of Physicians
The Royal College of Physicians Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The American Society For Histocompatibility & Immunogenetics
The American Society For Histocompatibility & Immunogenetics Miscellaneous Commercial ServicesCommercial Services Operates as a professional organization related to histocompatibility and immunogenetics | Commercial Services |
Immunovant, Inc.
 Immunovant, Inc. BiotechnologyHealth Technology Develops restorative therapies for autoimmune diseases | Health Technology |
- Stock Market
- Insiders
- Ian Gourley
